TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · major macro event coming up
VRSK

Verisk Analytics Inc

Industrials · Consulting Services

181.20$ -5.5% vs. previous close Closing price · As of: Aug 10, 2026

Statements

Segments

US companies must disclose in their mandatory reports how revenue breaks down across business segments, regions and product lines. We read that breakdown for you straight from the annual and quarterly reports (10-K and 10-Q) of Verisk Analytics Inc (VRSK). It shows which part of the business is growing — and which one is holding it back.

Revenue by business segment

Revenue by business segment — VRSK
Segment 2020 2021 2022 2023 2024
Insurance [Member] $2.01B 88.5% $2.21B 89.6% · +9.9% $2.44B 97.6% · +10.4% $2.68B 100.0% · +10.0% $2.88B 100.0% · +7.5%
Financial Services [Member] $156.7M 6.9% $142.8M 5.8% · -8.9% $37.6M 1.5% · -73.7% $0 0.0% · -100.0% $0 0.0%
Energy and Specialized Markets [Member] $104.0M 4.6% $112.8M 4.6% · +8.5% $22.4M 0.9% · -80.1%

Large figure: segment revenue. Below it the share of revenue in that period and the change against the prior year.

Revenue by region

Revenue by region — VRSK
Segment 2020 2021 2022 2023 2024 2025
UNITED STATES $1.91B 84.2% $2.06B 83.6% · +7.7% $2.12B 84.9% · +3.0% $2.24B 83.5% · +5.6% $2.39B 82.8% · +6.6% $2.52B 82.1% · +5.7%
Other Countries [Member] $217.0M 9.6% $235.8M 9.6% · +8.7% $207.4M 8.3% · -12.0% $253.0M 9.4% · +22.0% $281.2M 9.8% · +11.1% $300.3M 9.8% · +6.8%
UNITED KINGDOM $141.2M 6.2% $169.0M 6.9% · +19.7% $169.5M 6.8% · +0.3% $190.1M 7.1% · +12.2% $214.4M 7.4% · +12.8% $250.1M 8.1% · +16.7%

Large figure: segment revenue. Below it the share of revenue in that period and the change against the prior year.

Segment and region names are the ones the company itself uses and are shown as reported. Change and share refer to revenue.

Data as of: August 10, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Segment figures: SEC EDGAR (10-K/10-Q reports)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?